α‐Synuclein as a Target for Metallo‐Anti‐Neurodegenerative Agents
Angewandte Chemie International Edition · 02.01.2023 · 62 (1)
DOI: 10.1002/anie.202215360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 30.11.2022. Verfasst von Kaiming Cao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Department of Neurosurgery, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Department of Chem…. Hauptthemen laut MEDLINE: Parkinson Disease, Ruthenium, Organometallic Compounds. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The unique thermodynamic and kinetic coordination chemistry of ruthenium allows it to modulate key adverse aggregation and membrane interactions of α‐synuclein (α‐syn) associated with Parkinson's disease. We show that the low‐toxic Ru III complex trans ‐[ImH][RuCl 4 (Me 2 SO)(Im)] (NAMI‐A) has dual inhibitory effects on both aggregation and membrane interactions of α‐syn with submicromolar affinity, and disassembles pre‐formed fibrils. NAMI‐A abolishes the cytotoxicity of α‐syn towards neuronal cells and mitigates neurodegeneration and motor impairments in a rat model of Parkinson's. Multinuclear NMR and MS analyses show that NAMI‐A binds to residues involved in protein aggregation and membrane binding. NMR studies reveal the key steps in pro‐drug activation and the effect of activated NAMI‐A species on protein folding. Our findings provide a new basis for designing ruthenium complexes which could mitigate α‐syn‐induced Parkinson's pathology differently from organic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Department of Neurosurgery, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Department of Chemistry, University of Science and Technology of China, Hefei, 230026, C…
- Department of Chemistry, University of Warwick, Coventry, CV4 7AL, UK.
ORCID-Profile: Peter J Sadler, Yangzhong Liu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Cao, K., Zhu, Y., Hou, Z., Liu, M., Yang, Y., Hu, H., Dai, Y., Wang, Y., Yuan, S., Huang, G., Mei, J., Sadler, P. J., & Liu, Y. (2023). α‐Synuclein as a Target for Metallo‐Anti‐Neurodegenerative Agents. Angewandte Chemie International Edition, 62(1). https://doi.org/10.1002/anie.202215360
Vancouver
Cao K, Zhu Y, Hou Z, Liu M, Yang Y, Hu H, et al. α‐Synuclein as a Target for Metallo‐Anti‐Neurodegenerative Agents. Angewandte Chemie International Edition. 2023;62(1). doi:10.1002/anie.202215360
BibTeX
@article{Cao2023,
author = {Cao, Kaiming and Zhu, Yang and Hou, Zhuanghao and Liu, Manman and Yang, Yanyan and Hu, Hongze and Dai, Yi and Wang, Yu and Yuan, Siming and Huang, Guangming and Mei, Jiaming and Sadler, Peter J and Liu, Yangzhong},
title = {α‐Synuclein as a Target for Metallo‐Anti‐Neurodegenerative Agents},
journal = {Angewandte Chemie International Edition},
year = {2023},
volume = {62},
number = {1},
doi = {10.1002/anie.202215360}
}
EUVIMED